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In this work hydroxyapatite was precipitated from calcium hydroxide and phosphoric acid. Calcium hydroxide forms in 
addition to hydroxyapatite in samples with calcium to phosphorus ratio more than the stoichiometric one (Ca/P = 1.67). The 
effect of changing the pH of the precipitation solution was investigated. Changing the pH of solution had no effect on the 
amount of compounds formed in the structure. In contrast, an increase in Ca/P ratio increases the total amount of calcium 
hydroxide which is suitable for dental composite application.
INTRODUCTION
  Hard tissues repair has always been one of the most 
important issues in biomedical engineering [1]. Various 
biomaterials, such as different kinds of calcium phos-
phates, bioglasses, biopolymers, and synthetic polymers, 
have been studied in this area [2-5]. The most important 
properties  of  a  biomaterials  used  for  bone  repair 
are  osteoconductivity  and  osteoinductivity.  Among 
biomaterials,  calcium  phosphate  ceramics  have  been 
widely  used  in  orthopedics  and  dentistry  [6-11]  and 
Hydroxyapatite  (HA)  is  the  most  researched  calcium 
phosphate biomaterial in hard tissue repair applications. 
HA  comprising  60  to  70  percent  of  the  bone  tissue 
which  reduces  inflammation  and  immunogenic  reac-
tions at implantation site. Osteoconductivity is another 
property  of  HA  and  promotes  osseointegration  and 
contributes  to  osteogenesis.Some  clinical  applications 
of hydroxyapatite are: Bone defects repair, bone aug-
mentation,  and  coatings  for  human  body  metallic 
implants  [1-3,  9-20,  23,  25].  Therefore  tendency  to 
continue the research on HA as a biomaterial for hard 
tissue applications is growing. 
  There are various ceramic processing methods for 
HA synthesis such as precipitation, sol-gel, hydrothermal 
processing,  etc.  [4,  6,  10].  In  this  work,  HA  was 
precipitated from phosphoric acid and calcium phosphate 
and  the  stoichiometric  calcium  to  phosphorus  (Ca/P) 
ratio for HA synthesis is 1.67. Higher Ca/P ratio results 
in the formation of calcium hydroxide in addition to HA. 
The effect of different pH of the precipitation solution 
on the properties of HA was investigated. Properties of 
synthesized powders were characterized for use as dental 
composites.
EXPERIMENTAL
  Samples  were  prepared  by  aqueous  precipitation 
reaction. Suspensions of 0.5 molar calcium hydroxide 
were prepared using calcium hydroxide powder (Merck). 
The suspensions were degassed, vigorously stirred and 
heated to 40°C for two hours. A 0.3 molar phosphoric 
acid (Merck) solution was added drop by drop to the 
calcium hydroxide suspension and kept for an hour. 
  The obtained mixture was then stirred by a magnetic 
stirrer for 2 hours at the speed of 200 rpm, aged for 24 
hours at room temperature and centrifuged to complete 
the precipitation process. The precipitate was dried at 
100°C during 12 hours. The procedure was carried out 
with different ratios of calcium hydroxide and phosphoric 
acid to obtain desired Ca/P ratios. The pH of the mixture 
was  adjusted  using  ammonium  hydroxide  (Merck). 
Powders were characterized using EDS, FTIR, and XRD 
spectra. Scanning electron microscopy (SEM) was used 
to characterize the morphology of the specimens.
RESULTS AND DISCUSSION
  Data  gathered  from  the  synthesized  samples  is 
shown in Table 1.
	 EDS spectra (Figure 1) shows the Ca/P ratio of the 
samples A, D, and G. XRD spectra of the samples are 
shown in Figures 2,3, and 4.As can be seen in the figures, 
calcium hydroxide is formed in addition to HA in samples 
with Ca/P ratio more than 1.67 (the stoichiometric ratio). 
FTIR  spectra  shows  the  formation  of  OH  bonds  due 
to the existence of calcium hydroxide in the structure 
(Figure 5).Ansari M., Naghib S. M., Moztarzadeh F., Salati A.
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  Figure  2  depicts  SEM  micrographs  of  samples 
with the Ca/P ratios of 1.67, 1.8, and 1.9. Agglomerated 
hydroxyapatite crystals with needle-like and plate-like 
shapes can be observed in the figure.
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Figure 1.  EDS spectra of the samples with Ca/P ratio: a) 1.67, 
b) 1.8, c) 1.9.
c)
b)
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Table 1.  Characterization of the synthesized powders at 40°C..
  Sample code  Ca/P ratio  precipitation pH
  A  1.67  7.5
  B  1.67  9.5
  C  1.67  11.5
  D  1.8  7.5
  E  1.8  9.5
  F  1.8  11.5
  G  1.9  7.5
  H  1.9  9.5
  I  1.9  11.5
Figure 2.  SEM micrographs of the samples with Ca/P ratio: 
a) 1.67, b) 1.8, c) 1.9.
a)
b)
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  According to the results, in samples with Ca/P ratio 
more  than  the  stoichiometric  one,  calcium  hydroxide 
forms  in  addition  to  HA.  The  presence  of  calcium 
hydroxide in the structure is ideal for dental composites 
applications.  In  fact,  this  leads  to  an  increase  in  the 
amount  of  free  calcium  hydroxide  and  its  dissolution 
in  the  environment  which  increases  pH  and  reduces 
bacteria  growth.  Calcium  hydroxide  has  antibacterial 
characteristics,  enhances  enzymes  and  growth  factors 
release, and increases the rate of drug release [24, 25].
  As  shown  in  XRD  spectra  (Figures  2,3,  and  4), 
any change in the pH of the precipitation solution have 
no effect on the amount of the formed compounds but 
by  increasing  the  Ca/P  ratio,  the  amount  of  calcium 
hydroxide increases which is suitable for use in dental 
composites. 
CONCLUSION
  Calcium  hydroxide  is  formed  in  the  structure  of 
hydoxyapatite  precipitated  from  calcium  hydroxide 
and  phosphoric  acid  with  Ca/P  ratio  more  than  the 
stoichiometric  one  (1.67).  The  presence  of  calcium 
hydroxide in the structure leads to an increase in the 
amount  of  free  calcium  hydroxide  and  its  dissolution 
in  the  environment  which  increases  pH  and  reduces 
bacteria  growth.  Calcium  hydroxide  has  antibacterial 
characteristics,  enhances  enzymes  and  growth  factors 
release, and increases the rate of drug release.
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